Literature DB >> 21164038

Intraesophageal administration of GS-nitroxide (JP4-039) protects against ionizing irradiation-induced esophagitis.

Michael W Epperly1, Julie P Goff, Song Li, Xiang Gao, Peter Wipf, Tracy Dixon, Hong Wang, Darcy Franicola, Hongmei Shen, Jean-Claude M Rwigema, Valerian Kagan, Mark Bernard, Joel S Greenberger.   

Abstract

BACKGROUND/AIM: this study evaluated esophageal radioprotection by the Gramicidin S (GS) derived-nitroxide, JP4-039, a mitochondrial targeting peptide-isostere covalently-linked to 4-amino-Tempo, delivered in a novel swallowed oil-based (F15) formulation.
MATERIALS AND METHODS: C57BL/6HNsd female mice received intraesophageal F15 formulation containing JP4-039 (4 mg/ml in 100 microl volumes) 10 minutes before 28 or 29 Gy upper body irradiation compared to MnSOD-PL (100 microl containing 100 microg plasmid) 24 hours prior to irradiation. Subgroups received 1 × 10(7) C57BL/6HNsd, GFP(+) male bone marrow cells intravenously 5 days after irradiation.
RESULTS: JP4-039/F15 or MnSOD-PL increased survival compared to irradiated controls (p<0.0001 for either). Marrow injection further increased survival (p=0.0462 and 0.0351, respectively). Esophagi removed at 1, 3, 7, 14, 24, or 60 days showed bone marrow-derived cells in the esophagi.
CONCLUSION: intraesophageal GS-nitroxide radioprotection is mediated primarily through recovery of endogenous esophageal progenitor cells.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21164038      PMCID: PMC3521523     

Source DB:  PubMed          Journal:  In Vivo        ISSN: 0258-851X            Impact factor:   2.155


  36 in total

1.  Esophagus sparing with IMRT in lung tumor irradiation: an EUD-based optimization technique.

Authors:  Olivier Chapet; Emma Thomas; Marc L Kessler; Benedick A Fraass; Randall K Ten Haken
Journal:  Int J Radiat Oncol Biol Phys       Date:  2005-09-01       Impact factor: 7.038

2.  Protection of esophageal multi-lineage progenitors of squamous epithelium (stem cells) from ionizing irradiation by manganese superoxide dismutase-plasmid/liposome (MnSOD-PL) gene therapy.

Authors:  Yunyun Niu; Hongmei Shen; Michael Epperly; Xichen Zhang; Suhua Nie; Shaonan Cao; Joel S Greenberger
Journal:  In Vivo       Date:  2005 Nov-Dec       Impact factor: 2.155

3.  Formation of high axial ratio microstructures from peptides modified with glutamic acid dialkyl amides.

Authors:  K C Lee; A N Lukyanov; M H Gelb; P Yager
Journal:  Biochim Biophys Acta       Date:  1998-05-28

4.  Intratracheal injection of manganese superoxide dismutase (MnSOD) plasmid/liposomes protects normal lung but not orthotopic tumors from irradiation.

Authors:  M W Epperly; S Defilippi; C Sikora; J Gretton; A Kalend; J S Greenberger
Journal:  Gene Ther       Date:  2000-06       Impact factor: 5.250

5.  Evaluation of the hydroxylamine Tempol-H as an in vivo radioprotector.

Authors:  S M Hahn; M C Krishna; A M DeLuca; D Coffin; J B Mitchell
Journal:  Free Radic Biol Med       Date:  2000-03-15       Impact factor: 7.376

6.  MnSOD-plasmid liposome gene therapy decreases ionizing irradiation-induced lipid peroxidation of the esophagus.

Authors:  Michael W Epperly; Yulia Y Tyurina; Suhua Nie; Yun Yun Niu; Xichen Zhang; Valerian Kagan; Joel S Greenberger
Journal:  In Vivo       Date:  2005 Nov-Dec       Impact factor: 2.155

7.  Prevention of irradiation-induced esophagitis by plasmid/liposome delivery of the human manganese superoxide dismutase transgene.

Authors:  R L Stickle; M W Epperly; E Klein; J A Bray; J S Greenberger
Journal:  Radiat Oncol Investig       Date:  1999

8.  Polyethylene glycol-mediated cell fusion.

Authors:  Jian Yang; Ming Hong Shen
Journal:  Methods Mol Biol       Date:  2006

9.  Predictors of acute esophagitis in patients with non-small-cell lung carcinoma treated with concurrent chemotherapy and hyperfractionated radiotherapy followed by surgery.

Authors:  Ashish B Patel; Martin J Edelman; Young Kwok; Mark J Krasna; Mohan Suntharalingam
Journal:  Int J Radiat Oncol Biol Phys       Date:  2004-11-15       Impact factor: 7.038

10.  In vitro differentiation capacity of esophageal progenitor cells with capacity for homing and repopulation of the ionizing irradiation-damaged esophagus.

Authors:  Michael W Epperly; Hongmei Shen; Mia Jefferson; Joel S Greenberger
Journal:  In Vivo       Date:  2004 Nov-Dec       Impact factor: 2.155

View more
  25 in total

1.  GS-nitroxide (JP4-039)-mediated radioprotection of human Fanconi anemia cell lines.

Authors:  Mark E Bernard; Hyun Kim; Hebist Berhane; Michael W Epperly; Darcy Franicola; Xichen Zhang; Frank Houghton; Donna Shields; Hong Wang; Christopher J Bakkenist; Marie-Celine Frantz; Erin M Forbeck; Julie P Goff; Peter Wipf; Joel S Greenberger
Journal:  Radiat Res       Date:  2011-09-22       Impact factor: 2.841

2.  Dentofacial parameters explaining variability in retroclination of the maxillary central incisors.

Authors:  Bernd G Lapatki; Andreas Klatt; Jürgen Schulte-Mönting; Irmtrud E Jonas
Journal:  J Orofac Orthop       Date:  2007-03       Impact factor: 1.938

3.  Amelioration of radiation-induced pulmonary fibrosis by a water-soluble bifunctional sulfoxide radiation mitigator (MMS350).

Authors:  Ronny Kalash; Michael W Epperly; Julie Goff; Tracy Dixon; Melissa M Sprachman; Xichen Zhang; Donna Shields; Shaonan Cao; Darcy Franicola; Peter Wipf; Hebist Berhane; Hong Wang; Jeremiah Au; Joel S Greenberger
Journal:  Radiat Res       Date:  2013-10-14       Impact factor: 2.841

4.  Evaluation of Different Formulations and Routes for the Delivery of the Ionizing Radiation Mitigator GS-Nitroxide (JP4-039).

Authors:  Michael W Epperly; Peter Wipf; Renee Fisher; Darcy Franicola; Jan Beumer; Song Li; Rhonda M Brand; Louis D Falo; Geza Erdos; Joel S Greenberger
Journal:  In Vivo       Date:  2018 Sep-Oct       Impact factor: 2.155

5.  The zebrafish--Danio rerio--is a useful model for measuring the effects of small-molecule mitigators of late effects of ionizing irradiation.

Authors:  Michael W Epperly; Nathan Bahary; Mubina Quader; Valerie Dewald; Joel S Greenberger
Journal:  In Vivo       Date:  2012 Nov-Dec       Impact factor: 2.155

6.  Effectiveness of Analogs of the GS-Nitroxide, JP4-039, as Total Body Irradiation Mitigators.

Authors:  Michael W Epperly; Joshua R Sacher; Tanja Krainz; Xiaolin Zhang; Peter Wipf; Mary Liang; Renee Fisher; Song Li; Hong Wang; Joel S Greenberger
Journal:  In Vivo       Date:  2017-01-02       Impact factor: 2.155

Review 7.  Radioprotection of normal tissue cells.

Authors:  Patrick Maier; Frederik Wenz; Carsten Herskind
Journal:  Strahlenther Onkol       Date:  2014-03-18       Impact factor: 3.621

8.  Amelioration of radiation-induced oral cavity mucositis and distant bone marrow suppression in fanconi anemia Fancd2-/- (FVB/N) mice by intraoral GS-nitroxide JP4-039.

Authors:  Hebist Berhane; Ashwin Shinde; Ronny Kalash; Karen Xu; Michael W Epperly; Julie Goff; Darcy Franicola; Xichen Zhang; Tracy Dixon; Donna Shields; Hong Wang; Peter Wipf; Song Li; Xiang Gao; Joel S Greenberger
Journal:  Radiat Res       Date:  2014-06-16       Impact factor: 2.841

9.  Nanoassembly of surfactants with interfacial drug-interactive motifs as tailor-designed drug carriers.

Authors:  Xiang Gao; Yixian Huang; Alexander M Makhov; Michael Epperly; Jianqin Lu; Sheila Grab; Peijun Zhang; Lisa Rohan; Xiang-Qun Xie; Peter Wipf; Joel Greenberger; Song Li
Journal:  Mol Pharm       Date:  2012-12-17       Impact factor: 4.939

10.  Synthesis of analogs of the radiation mitigator JP4-039 and visualization of BODIPY derivatives in mitochondria.

Authors:  Marie-Céline Frantz; Erin M Skoda; Joshua R Sacher; Michael W Epperly; Julie P Goff; Joel S Greenberger; Peter Wipf
Journal:  Org Biomol Chem       Date:  2013-07-07       Impact factor: 3.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.